Volition | Jotup

The South China Sea: A Nuanced Understanding Required

Retrieved on:

월요일, 4월 22, 2024

Silk Road, Bias, The Business Council, Maritime Silk Road, Vietnam War, Transport, Globalization, Politics, Failure, Economic development, Volition, Government

The objective of these talks is to achieve a nuanced understanding of the activities surrounding this critical waterway and the potential impact on the corporate sector.

Key Points:

The objective of these talks is to achieve a nuanced understanding of the activities surrounding this critical waterway and the potential impact on the corporate sector.
"Most bilateral and multilateral efforts relating to activities in the South China Sea are largely government to government.
A nuanced understanding is required for every organisation in any given jurisdiction.
Businesses operating in the South China Sea must diversify supply chains, invest in alternative transportation routes, and engage in corporate diplomatic initiatives to safeguard their interest.

Screenverse Secures $10.5 Million Investment to Empower DOOH Media Owners with Programmatic Advertising Solutions

Retrieved on:

화요일, 4월 30, 2024

7-Eleven, Walmart, Ecosystem, Kroger, Partnership, DOOH, Volition, Advertising, CPM, Growth

NEW YORK, April 30, 2024 /PRNewswire-PRWeb/ -- Screenverse, a monetization and ad management partner for DOOH (digital-out-of-home) media owners, announced a $10.5 million investment led by Volition Capital. This funding round marks a pivotal moment for Screenverse as it aims to accelerate DOOH advertising's programmatic future.

Key Points:

NEW YORK, April 30, 2024 /PRNewswire-PRWeb/ -- Screenverse , a monetization and ad management partner for DOOH (digital-out-of-home) media owners, announced a $10.5 million investment led by Volition Capital .
This funding round marks a pivotal moment for Screenverse as it aims to accelerate DOOH advertising's programmatic future.
Screenverse's suite of services is tailored to meet the evolving needs of DOOH media owners, offering end-to-end support in programmatic advertising monetization and management.
"We are thrilled to lead this investment round and support Screenverse in its mission to drive value for media owners and advertisers alike."

Antech’s breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection

Retrieved on:

화요일, 4월 23, 2024

A rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs, Nu.Q® testing also includes prevalent types of canine cancers, enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.

Key Points:

A rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs, Nu.Q® testing also includes prevalent types of canine cancers, enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.
Jimmy Barr, DVM, DACVECC, Chief Medical Officer at Antech, part of Mars Science & Diagnostics said: “It’s exciting to see innovations like Nu.Q® Canine Cancer Test become more widely available to veterinary teams in Europe.
This is what our work at Antech is all about.”
Nu.Q® Canine Cancer Test is a breakthrough technology that measures circulating nucleosomes, supporting earlier cancer detection in some of the most prevalent types of canine cancers.
ECVS, Tierklink Düsseldorf , used Nu.Q® Canine Cancer Test first-hand during the pilot phase and commented: “At our clinic, we see around 1500 cases of cancer in dogs a year.

Antech’s Breakthrough AI-powered Radiology and Targeted Cancer Screening Tools Now Available, Unleashing New Chapter for Veterinary Diagnostics

Retrieved on:

금요일, 4월 12, 2024

Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics.

Key Points:

Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics.
The webinar will be offered May 21 and 22, and veterinary professionals can sign up here on Antech’s website.
Also now available is Nu.Q® Canine Cancer Test, a rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs.
Nu.Q® cancer detection includes prevalent types of canine cancers enabling veterinarians and pet owners to make informed decisions about cancer care more quickly.

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech

Retrieved on:

화요일, 4월 23, 2024

Cancer, BMC, Pet, Sepsis, Veterinarian, Death, Volition, Neutrophil extracellular traps, Analyser, Dog, Plasma, Element, Vaccine

HENDERSON, Nev., April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech , a leading veterinary diagnostics company.

Key Points:

HENDERSON, Nev., April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech , a leading veterinary diagnostics company.
By incorporating the Nu.Q® Canine Cancer Test into annual checkups or regular senior wellness exams, veterinarians can detect cancer¹ earlier and help pet owners make timely, informed decisions about cancer care."
Volition's original license and supply agreement was between Belgian Volition SRL and Heska, an Antech company, part of Mars Science & Diagnostics.
https://doi.org/10.1186/s12917-022-03429-8
According to The Veterinary Cancer Society, one in four dogs will be diagnosed with cancer, and it's the leading cause of death in pets who are beyond middle age.

Volition Capital Appoints Pete Lamson as Chief Operating Officer and Head of Portfolio Operations to Drive Portfolio Company Success and Operational Excellence

Retrieved on:

화요일, 4월 16, 2024

Investment, Software, Carbonite, Harvard Business School, Culture, IPO, Volition, Acquisition, Middlebury College, Growth, Head, Management

BOSTON, April 16, 2024 /PRNewswire-PRWeb/ -- Volition Capital, a leading growth equity firm, today announces that Pete Lamson has joined the firm as Chief Operating Officer and Head of Portfolio Operations. Lamson brings over 35 years of leadership experience and a track record of driving accelerated revenue growth, operational excellence, and shareholder value creation.

Key Points:

BOSTON, April 16, 2024 /PRNewswire-PRWeb/ -- Volition Capital , a leading growth equity firm, today announces that Pete Lamson has joined the firm as Chief Operating Officer and Head of Portfolio Operations.
I look forward to partnering with Volition's talented team and portfolio company leaders to unlock new opportunities and drive sustainable, industry leading value creation.
Lamson joins Volition Capital as the firm is focused on expanding its investments and deepening its commitment to supporting portfolio companies in achieving their full potential.
The introduction of Lamson as Head of Portfolio Ops underscores the firm's commitment to investing in the success of portfolio companies through strategic guidance and support.

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Retrieved on:

월요일, 3월 25, 2024

Conference call, Volition, Oncology, NETS, ESMO, Poster, Blood, FDA, Eastern Time Zone, Neoplasm, Cryptocurrency

HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal year ended December 31, 2023. Volition management will host a conference call tomorrow, March 26 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.

Key Points:

Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced financial results and a business update for the full fiscal year ended December 31, 2023.
Volition management will host a conference call tomorrow, March 26 at 8:30 a.m. U.S. Eastern Time to discuss these results.
Cameron Reynolds, President and Group Chief Executive Officer of Volition said: "2023 was certainly transformational for Volition and a year we can look back on with pride.
Cash and cash equivalents as of December 31, 2023, totaled approximately $20.7 million as compared to $10.9 million as of December 31, 2022.

Coinsilium Group Limited: Strategic Financing to Advance Web3 Operations and Investments

Retrieved on:

수요일, 3월 13, 2024

Social media, AI, Marketing, Exercise, Volition, Web3, Admission, Executive, Funding, Acceleration, Hand, Cryptocurrency

London, UK, 8 March 2024 – Coinsilium Group Limited (AQSE: COIN) (OTCQB: CINGF), the Web3 advisor, venture builder and investor is pleased to announce a strategic financing, with director participation (“Financing”).

Key Points:

London, UK, 8 March 2024 – Coinsilium Group Limited (AQSE: COIN) (OTCQB: CINGF), the Web3 advisor, venture builder and investor is pleased to announce a strategic financing, with director participation (“Financing”).
Included within the Financing, Malcolm Palle (Executive Chairman) and Eddy Travia (Chief Executive Officer) are participating with a subscription of £40,000 in total as outlined in further detail below.
The Financing underpins the Company’s working capital position and importantly, enables an acceleration of certain operational and investing activities at a time when AI and Web3 are rapidly advancing and Coinsilium wishes to remain at the forefront of various Web3 technology initiatives.
Further announcements will follow in respect of business developments enabled through this Financing.

EQS-News: Changes to the Supervisory Board of Klöckner & Co SE

Retrieved on:

수요일, 3월 13, 2024

CFO, Internal audit, Supervisory board, Rheinmetall, Supervision, Volition, Audit committee, Digitalization, Knowledge, Annual, Property management

In light of the upcoming replacement, the Supervisory Board will propose to the shareholders of Klöckner & Co SE in the invitation to the Annual General Meeting that Ms. Dagmar Steinert be elected to the company’s Supervisory Board.

Key Points:

In light of the upcoming replacement, the Supervisory Board will propose to the shareholders of Klöckner & Co SE in the invitation to the Annual General Meeting that Ms. Dagmar Steinert be elected to the company’s Supervisory Board.
Dieter H. Vogel, Head of the Supervisory Board of Klöckner & Co SE: “For the last seven years, Ute Wolf has supported the Supervisory Board and the company with her great expertise and extensive knowledge.
On behalf of the Supervisory Board and the Management Board, we would like to express our sincere gratitude for her dedication.
If Dagmar Steinert is elected by the Annual General Meeting, she will become a member of the Audit Committee of the Supervisory Board.

Relish Raises Funding to Transform How Businesses Maximize the Value of ERP and Source-to-Pay Software Investments

Retrieved on:

목요일, 2월 29, 2024

Acquisition, AI, Investment, SAP, Health, Data management, Growth, B2B, Ecosystem, Automation, Volition, Software, Partnership

CLEVELAND, Feb. 29, 2024 /PRNewswire-PRWeb/ -- Relish, the leading provider of solutions for businesses to optimize procurement systems and processes, today announced it closed a $10M Series A funding round from Boston-based growth equity firm, Volition Capital. Since its founding in 2020, the company rapidly established itself as a dominant provider of solutions that enable customers to optimize and maximize the value of their existing procurement software investments such as SAP, Coupa, and Workday.

Key Points:

The need for custom solutions for most enterprise software users was very apparent and our mission with Relish is to help businesses to maximize their existing IT investments.
The procurement software market size is projected to grow from $6.67 billion in 2022 to $13.80 billion by 2029 .
Consumer goods, energy, financial services, healthcare, and public sector businesses have invested heavily in enterprise software to manage procurement processes and spend.
"The need for custom solutions for most enterprise software users was very apparent and our mission with Relish is to help businesses to maximize their existing IT investments.